XiaoMi-AI文件搜索系统
World File Search System叶列
橄榄叶提取物对学习和记忆的影响...
目的：利用 Morris 水迷宫 (MWM) 测试研究橄榄叶提取物 (OLE) 对链脲佐菌素 (STZ) 诱发的糖尿病大鼠学习和记忆能力的影响。方法：将 32 只雄性 Wistar 白化大鼠随机分为四组：对照组 (第 1 组)、STZ 诱发的糖尿病组 (第 2 组)、STZ + OLE (第 3 组)、OLE + STZ (第 4 组)。治疗组 (第 3、4 组) 口服 0.5 g/kg OLE，持续六周。进行 MWM 测试以评估找到平台的潜伏期、游泳总距离和平均速度。检查海马组织以测量酶活性（丙二醛（MDA）、过氧化氢酶（CAT）、超氧化物歧化酶（SOD）和谷胱甘肽过氧化物酶（GPx）。在研究前和手术前记录血糖水平。结果：对照组和治疗组到达平台的潜伏期较短，对照组和OLE+STZ组的减少最为显著。在第5天，OLE+STZ组游泳距离最短。随着时间的推移，第2组和治疗组的游泳距离显著减少。各组之间平均速度差异仅在第1天显着。第2组的MDA水平高于对照组，但治疗组的MLA降低，尤其是OLE+STZ组。与第2组相比，所有组的CAT水平均升高。与第2组相比，对照组和OLE+STZ组的GPx和SOD水平升高。OLE+STZ组的GPx和SOD水平高于STZ+OLE组。与第 2 组相比，对照组和治疗组的血糖水平下降，其中 OLE + STZ 组的下降幅度最大。讨论：OLE 降低了糖尿病大鼠的氧化应激并改善了学习和记忆能力，在 STZ 给药前接受 OLE 的组效果更明显。
量子贝叶斯计算
量子贝叶斯计算 (QBC) 是一个新兴领域，它利用量子计算机的计算优势，为贝叶斯计算提供指数级加速。我们的论文以两种方式丰富了文献。首先，我们展示了如何使用冯·诺依曼量子测量来模拟机器学习算法，例如马尔可夫链蒙特卡罗 (MCMC) 和深度学习 (DL)，这些算法是贝叶斯学习的基础。其次，我们描述了实现量子机器学习所需的数据编码方法，包括传统特征提取和核嵌入方法的对应方法。我们的目标是展示如何将量子算法直接应用于统计机器学习问题。在理论方面，我们提供了高维回归、高斯过程 (Q-GP) 和随机梯度下降 (Q-SGD) 的量子版本。在经验方面，我们将量子 FFT 模型应用于芝加哥住房数据。最后，我们总结了未来研究的方向。
通过合并贝叶斯网络
我们介绍了基于快速贪婪的等效搜索算法，通过合并本地学到的贝叶斯网络来学习基因调节网络的结构的新方法，用于学习基因调节网络的结构。该方法在Matthews相关系数方面与艺术的状态具有竞争力，该系数既考虑到精度和召回率，同时也可以在速度方面进行改进，扩展到数万个变量，并能够使用有关基因调节网络拓扑结构的经验知识。为了展示我们的方法扩展到大规模网络的能力，我们使用来自不同大脑结构的样本（来自艾伦人脑大脑图书馆）的数据来学习全人类基因组的基因调节网络。此外，这种贝叶斯网络模型应以专家的清晰度来预测基因之间的相互作用，遵循当前可解释的人工智能的趋势。为了实现这一目标，我们还提出了一种新的开放式可视化工具，该工具促进了大规模网络的探索，并可以帮助寻找感兴趣的体验测试节点。
201使用叶甲醇提取物...
已经对使用Kaliandra叶甲醇提取物作为铁金属腐蚀抑制剂的抽象研究进行了研究。本研究的目的是确定在HCl培养基中铁金属抑制过程中浸泡时间，浓度和温度变化中，Kaliandra叶提取物（Calliandra calothyrsus M.）中包含的二级代谢产物和最佳条件。kaliandra叶提取物是通过用甲醇溶剂浸润提取的。使用减少浸泡时间，kaliandra叶提取物的浓度和温度来确定每年的腐蚀速率和抑制效率％的腐蚀测试。结果表明，kaliandra叶甲醇提取物含有二级代谢化合物生物碱，类黄酮，单宁和皂苷。在6天的抑制作用时，获得了HCL腐蚀性培养基上铁金属抑制过程的最佳条件，抑制效率和腐蚀速率值为86.49％和0.00119 mm/年，并以13,000 ppm的浓度和温度为26℃年度和91.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.60％。在使用温度变化的浸入中，所使用的温度越高，抑制效率降低和腐蚀速率增加，以使铁金属经历更快的腐蚀。
使用贝叶斯网络
为了比较定理2和4，我们从[5，表1]中的每一行选择相同的Q，n，c和ℓ= k 1 + k 2。对于Q，n，c和ℓ= k 1 + k 2的元组，它们[5，sec。vi]还引入了集合P，以量化给定参数的最大可能距离q，n，c和ℓ= k 1 + k 2，通过该版本的GV边界来确保存在量子代码的存在。具体而言，对于固定值（q，n，k 1，k 2，c）（或（q，n，ℓ= k 1 + k 2，c）），我们考虑z-最小和x-最小距离的p旧（d 1，d 2）的集合（d 1，d 2）和x-毫米最低距离的不对称eaqeccs（d），d 1，d 1，d 2 2），但（5）die（5）die（5）或die（5）或die（5）或die（或满足）或die（或满足die（die），或（或满足d），或（5），或满足（5），或满足（5）或die（或满足d）。 ，d 2）或（d 1，d 2 + 1）分别违反了不平等（5）[或不平等（1）]。对于任何（d 1，d 2）∈P旧存在（d'
基于直列拓扑的多频带 SIW 带通滤波器的合成与实现
摘要 — 本文提出了一种用于多频带带通滤波器 (MBPF) 的相似变换方法，将星型拓扑转换为直列拓扑。介绍了一种通用理论技术，用耦合矩阵的相似变换旋转代替传统的通过滤波器综合逐步提取 LC 电路，解决了参数提取过程中的舍入误差，提高了理论综合结果的准确性。直列拓扑的应用大大提高了滤波器设计的灵活性，降低了电路复杂性，简化了高阶 MBPF 的制造。基于基片集成波导 (SIW) 技术，设计和实现了一系列示例，包括三频、四频，特别是首次报道的五频三阶切比雪夫 SIW 带通滤波器。模拟响应与测量结果之间具有良好的一致性，验证了设计的滤波器模型和提出的理论方法。
利物浦约翰列侬机场 2050 年总体规划
利物浦是一座国际化城市。它以商业为基础，保留了引以为豪的贸易传统和对外关注。利物浦约翰列侬机场 (LJLA) 既是通往利物浦市区 (LCR) 的国际门户，也是当地经济的主要推动力，发挥着重要作用。它为该地区提供了约 6,000 个工作岗位，并为 LCR 的经济贡献了 2.5 亿英镑的 GVA。这座充满活力且不断发展的机场的存在也成为利物浦南部重塑的催化剂。机场有潜力做更多的事情，我们渴望发挥这一潜力，造福利物浦市区及其他地区。本总体规划确认了 LJLA 未来的长期愿景，并描述了机场及其周边土地的进一步投资提案。它详细考虑了机场到 2030 年的提案，并提供了到 2050 年的潜在发展的广泛指示。
XIGDUO®（达格列净和盐酸二甲双胍片）
二甲双胍通过肾脏消除，由于肾功能不全患者发生严重不良反应的风险更大，因此 XIGDUO 禁用于严重肾功能不全（估计肾小球滤过率 (eGFR) <30 mL/min/1.73 m 2 ）患者。请参阅肾脏。由于衰老与肾功能下降有关，因此不应在 80 岁以上的患者中开始 XIGDUO 治疗，除非他们的肾功能没有显著下降。对于高龄患者，应仔细滴定 XIGDUO 以确定足够血糖作用的最低剂量。需要更仔细和频繁地监测肾功能，以帮助预防二甲双胍相关的乳酸性酸中毒。见 4.1 剂量注意事项、4.2 推荐剂量和剂量调整、内分泌和代谢、乳酸性酸中毒、7.1.4 老年病学。
列治文山官方规划第 18.2 号修正案
• 该修正案符合《省级政策声明（2020 年）》，该声明要求市政当局规划并适应现有定居区内的集约化和再开发，以创建更可持续的社区并更有效地利用土地和基础设施； • 该修正案符合《成长之地：大金马蹄地区增长计划（2019 年）》，该计划支持实现完整的社区，这些社区具有多样化的土地用途，并方便获得当地商店、服务和公共服务设施； • 该修正案符合《约克区官方计划（2010 年）》，该计划将主题土地指定为“城市区域”，并鼓励在城市区域边界内进行集约化和再开发。此外，建议通过该地区的市政综合审查将这些土地排除在该地区就业用地之外
重新列出了dna de dna delinfócitost
Figura 1: Desenho esquemático dos componentes presentes nas redes extracelulares de DNA em neutrófilos ................................................................................................................................................17 Figura 2: Representação esquemática da via da Netose ........................................................................19 Figura 3: Desenho experimental .................................................................................................................28 Figura 4: Estratégia de análise para avaliar a frequência das populações de CD14+,CD19+, CD4+ e CD8+ após a Marcaçãocomanticorpos antisubpopulaçõescelulares eaquisiçãoporcitometriade fluxo。..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 38图5：富集淋巴细胞的细胞组成的细胞仪分析。。...................................................................................................................................................39 Figura 6: Avaliação da porcentagem de morte celular por citometria de fluxo ................................... 40 Figure 7: Evaluation, in lymphocyte -enriched crops, by confocal microscopy, of the occurrence of extracellular DNA. 在 ................. 51 Figure 15: SME evaluation of CD4+ and CD8+ T lymphocytes................................... 40 Figure 7: Evaluation, in lymphocyte -enriched crops, by confocal microscopy, of the occurrence of extracellular DNA.在................. 51 Figure 15: SME evaluation of CD4+ and CD8+ T lymphocytes.................. 51 Figure 15: SME evaluation of CD4+ and CD8+ T lymphocytes........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 46 Figure 11: Extracellular networks blushed by DAPI do not have actin. ............................... 47 Figure 12 Electronic microscopy assessment of scanning the presence of extracellular networks in lymphocyte -enriched crops. .......................................................................... 50 Figure 13 Electronic Microscopy Evaluation of Internal Morphology Transmission of Lymphocytes. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ......................................................... 52 Figure 16: Evaluation of the percentage of cell death by CD4+ and CD8+ T lymphocyte flow cytometry. .............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54 在........................................... 46 Figure 11: Extracellular networks blushed by DAPI do not have actin................................ 47 Figure 12 Electronic microscopy assessment of scanning the presence of extracellular networks in lymphocyte -enriched crops. .......................................................................... 50 Figure 13 Electronic Microscopy Evaluation of Internal Morphology Transmission of Lymphocytes. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ......................................................... 52 Figure 16: Evaluation of the percentage of cell death by CD4+ and CD8+ T lymphocyte flow cytometry. .............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54 在............................... 47 Figure 12 Electronic microscopy assessment of scanning the presence of extracellular networks in lymphocyte -enriched crops........................................................................... 50 Figure 13 Electronic Microscopy Evaluation of Internal Morphology Transmission of Lymphocytes. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ......................................................... 52 Figure 16: Evaluation of the percentage of cell death by CD4+ and CD8+ T lymphocyte flow cytometry. .............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54 在.......................................................................... 50 Figure 13 Electronic Microscopy Evaluation of Internal Morphology Transmission of Lymphocytes................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 52 Figure 16: Evaluation of the percentage of cell death by CD4+ and CD8+ T lymphocyte flow cytometry. .............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54 在......................................................... 52 Figure 16: Evaluation of the percentage of cell death by CD4+ and CD8+ T lymphocyte flow cytometry............................................................................................................................................................................................................................................................................................................................................................................................................................................................... 54 在.............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54在.............................................. 55 Figure 18 Evaluation by CD107 + cell frequency flow cytometry 56 Figure 19: Immunofluorescence of CD8 +, Lets and CD107. ........................ 58 Figure 21: Evaluation of cellular composition of patient injuries through histopathological analysis by hematoxylin/eosin coloration. ........................................................................59 Figura 22: Avaliação da composição celular de lesões de pacientes com LTA ..................................60 Figura 23 : Avaliação por microscopia confocal de ETs em lesões de pacientes da forma cutânea da LTA . ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. .............................................................................................. 65.............................................. 55 Figure 18 Evaluation by CD107 + cell frequency flow cytometry 56 Figure 19: Immunofluorescence of CD8 +, Lets and CD107......................... 58 Figure 21: Evaluation of cellular composition of patient injuries through histopathological analysis by hematoxylin/eosin coloration. ........................................................................59 Figura 22: Avaliação da composição celular de lesões de pacientes com LTA ..................................60 Figura 23 : Avaliação por microscopia confocal de ETs em lesões de pacientes da forma cutânea da LTA . ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. .............................................................................................. 65........................ 58 Figure 21: Evaluation of cellular composition of patient injuries through histopathological analysis by hematoxylin/eosin coloration.........................................................................59 Figura 22: Avaliação da composição celular de lesões de pacientes com LTA ..................................60 Figura 23 : Avaliação por microscopia confocal de ETs em lesões de pacientes da forma cutânea da LTA .............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 65.............................................................................................. 65